Brief: Kuros Biosciences Enters Convertible Bond Financing Agreement For Up To CHF 5 Mln
April 9 (Reuters) - Kuros Biosciences AG KURN.S :
* KUROS BIOSCIENCES ENTERS CONVERTIBLE BOND FINANCING AGREEMENT FOR UP TO CHF 5 MILLION
* AGREEMENT WITH NICE & GREEN S.A. CAN BE EXTENDED FOR AN ADDITIONAL CHF 5 MILLION
* PROVIDES ADDITIONAL FUNDS FOR ROLL-OUT OF MAGNETOS AND FURTHER ADVANCING CLINICAL PROGRAM
Source text for Eikon: ID:nTENa7e5aa
Further company coverage: KURN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million